APC anti-Human CD48
| Catalog number: | B2015672 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 tests |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20 C |
| Keywords: | APC anti-human CD48 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Abada-Molina AC, Ji H, Faubion WA, Julien A, Latchman Y, Yagita H, Sharpe A, Bhan AK, Terhorst C. CD48 controls T-cell and antigen-presenting cell functions in experimental colitis Gastroenterology. 2006 Feb;130(2):424-34.
- Geisberg M, Terry LA, Flomenberg N, Dupont B. Cytotoxic and proliferative allospecific T-cell clones contain perforin and mediate anti-CD3-induced cytotoxicity Hum Immunol. 1992 Dec;35(4):239-45.
- Fodde R. The APC gene in colorectal cancer Eur J Cancer. 2002 May;38(7):867-71.
- Neufeld KL. Nuclear APC Adv Exp Med Biol. 2009;656:13-29.
- Fang X, Svitkina TM. Adenomatous Polyposis Coli (APC) in cell migration Eur J Cell Biol. 2022 Jun-Aug;101(3):151228.
- Yang X, Zhong J, Zhang Q, Feng L, Zheng Z, Zhang J, Lu S. Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy Front Mol Biosci. 2021 Apr 22;8:662579.
- Akiyama T. [The APC gene] Nihon Rinsho. 1996 Apr;54(4):955-9.
- Castoldi E, Rosing J. APC resistance: biological basis and acquired influences J Thromb Haemost. 2010 Mar;8(3):445-53.
- Takao M, Yamaguchi T, Eguchi H, Yamada T, Okazaki Y, Tomita N, Nomizu T, Momma T, Takayama T, Tanakaya K, Akagi K, Ishida H. APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients Int J Clin Oncol. 2021 Sep;26(9):1661-1670.
